Drug-like dietary vanilloids induce anticancer activity through proliferation inhibition and regulation of bcl-related apoptotic proteins

Phytotherapy Research : PTR
Chun-Wai MaiMallikarjuna Rao Pichika

Abstract

In this study, a series of 20 structurally similar vanilloids (Vn) were tested for their antiproliferative effects against 12 human cancer cells: human breast (MCF-7 and MDA-MB-231), cervical (HeLa), ovarian (Caov-3), lung (A549), liver (HepG2), colorectal (HT-29 and HCT116), nasopharyngeal (CNE-1 and HK-1), and leukemic (K562 and CEM-SS) cancer cells. Among all the tested vanilloids, Vn16 (6-shogaol) exhibited the most potent cytotoxic effects against human colorectal cancer cells (HT-29). The apoptotic induction effects exhibited by Vn16 on HT-29 cells were confirmed using dual staining fluorescence microscopy and enzyme-linked immunosorbent assay. The effects of Vn16 on regulation of 43 apoptotic-related markers were determined in HT-29. The results suggested that 8 apoptotic markers (caspase 8, BAD, BAX, second mitochondrial-derived activator, caspase 3, survivin, bcl-2, and cIAP-2) were either upregulated or downregulated. These results further support the chemopreventive properties of foods that contain vanilloids.

References

Aug 22, 2000·The Journal of Biological Chemistry·S M SrinivasulaE S Alnemri
Dec 2, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S ManusirivithayaK Tangcharoenpanich
Apr 4, 2009·Journal of Biomedicine & Biotechnology·Siddig Ibrahim Abdel WahabSyam Mohan
Apr 17, 2009·Journal of Agricultural and Food Chemistry·Kriengsak LirdprapamongkolJisnuson Svasti
Oct 17, 2009·Journal of Ethnopharmacology·Swarnalatha DugasaniJayaveera Narsimha Korlakunta
Feb 4, 2010·Anti-cancer Drugs·Francesco CaponigroFrancesco Perri
Mar 11, 2010·Current Medicinal Chemistry·G Bar-SelaM Schaffer
May 15, 2010·Bioorganic & Medicinal Chemistry·Delphine Lamoral-TheysJacques Dubois
Jul 6, 2010·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Ganiyu ObohAdedayo O Ademiluyi
Nov 3, 2010·Current Drug Delivery·Chandana MohantySanjeeb K Sahoo
Dec 2, 2010·Current Pharmaceutical Biotechnology·Chung-Pu WuSuresh V Ambudkar
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Apr 7, 2011·Current Pharmaceutical Biotechnology·Altaf S DarveshAnupam Bishayee
Nov 3, 2011·Journal of Signal Transduction·Gonzalo Rodríguez-BerrigueteMar Royuela
Jan 17, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Huadong ChenShengmin Sang
Nov 14, 2015·Current Cancer Drug Targets·Felicia Fei-Lei ChungChee-Onn Leong
Oct 18, 2016·Chemical Biology & Drug Design·Gajjela Bharath KumarHua-Li Qin

❮ Previous
Next ❯

Citations

Aug 23, 2019·Phytotherapy Research : PTR·Ester Pagano, Angelo A Izzo
Apr 17, 2019·Journal of Experimental & Clinical Cancer Research : CR·Chin-King LooiChun-Wai Mai
Aug 23, 2019·Journal of Natural Products·Nur V BihudNor Hadiani Ismail

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.